Silicon Laboratories (NASDAQ:SLAB) Given New $145.00 Price Target at Stifel Nicolaus

Silicon Laboratories (NASDAQ:SLAB) had its price target raised by investment analysts at Stifel Nicolaus from $135.00 to $145.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the semiconductor company’s stock. Stifel Nicolaus’ price objective suggests a potential upside of 12.30% from the company’s previous close.

Other research analysts also recently issued reports about the company. Morgan Stanley reduced their target price on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Barclays decreased their target price on Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. JPMorgan Chase & Co. lowered their target price on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a research note on Tuesday, November 5th. Susquehanna began coverage on shares of Silicon Laboratories in a research report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price target on the stock. Finally, KeyCorp lowered their price objective on shares of Silicon Laboratories from $150.00 to $115.00 and set an “overweight” rating for the company in a research report on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $123.56.

Silicon Laboratories Price Performance

Silicon Laboratories stock opened at $129.12 on Monday. The firm has a market capitalization of $4.19 billion, a P/E ratio of -17.45 and a beta of 1.17. The stock has a fifty day moving average price of $116.30 and a two-hundred day moving average price of $113.66. Silicon Laboratories has a 52-week low of $94.00 and a 52-week high of $154.91.

Silicon Laboratories (NASDAQ:SLAB) last announced its earnings results on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.07. The business had revenue of $166.00 million during the quarter, compared to analysts’ expectations of $165.50 million. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The firm’s revenue for the quarter was down 18.5% on a year-over-year basis. During the same quarter last year, the company posted $0.48 EPS. On average, equities research analysts predict that Silicon Laboratories will post -3.56 EPS for the current fiscal year.

Institutional Investors Weigh In On Silicon Laboratories

Institutional investors have recently modified their holdings of the business. FMR LLC lifted its holdings in Silicon Laboratories by 1.1% in the third quarter. FMR LLC now owns 4,843,370 shares of the semiconductor company’s stock valued at $559,748,000 after buying an additional 54,708 shares during the period. Wellington Management Group LLP lifted its stake in shares of Silicon Laboratories by 28.3% in the 3rd quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company’s stock valued at $102,670,000 after purchasing an additional 195,997 shares during the period. Geode Capital Management LLC boosted its position in shares of Silicon Laboratories by 2.1% in the 3rd quarter. Geode Capital Management LLC now owns 781,049 shares of the semiconductor company’s stock worth $90,282,000 after purchasing an additional 15,728 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Silicon Laboratories by 2.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 639,065 shares of the semiconductor company’s stock worth $70,699,000 after purchasing an additional 12,680 shares during the last quarter. Finally, Van Berkom & Associates Inc. grew its stake in shares of Silicon Laboratories by 8.4% during the second quarter. Van Berkom & Associates Inc. now owns 609,232 shares of the semiconductor company’s stock worth $67,399,000 after purchasing an additional 47,058 shares during the period.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.